The CDC's independent advisory panel has unanimously voted to recommend booster doses of Pfizer's COVID vaccine for people aged 65 and older, along with long-term care facility residents, at least six months after their second dose.
after the Biden administration announced"boosters-for-all" ahead of any reviews from the regulatory bodies, or their independent groups. While the White House's political appointees had endorsed Biden's timeline, some of their career scientists and advisers vehemently objected to the incomplete data they were being asked to assess.
"We all recognize that the science and data of COVID-19 are moving faster than any data we've ever seen before. And while I recognize a tremendously heavy lift of the past year, we all know that the pace is unlikely to let up anytime soon," she added."We will continue this dialogue, you will have more data to review and more recommendations to make and I will be here with you.
Panelists initially pushed back on the proposals that American adults, 18 to 64, who are at risk for severeinfection due to underlying medical conditions, or due to their occupation and setting receive a Pfizer booster dose. Many members stressed that in order to truly"move the dial" on the pandemic, more people need to complete the initial vaccination series.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC panel recommends Pfizer booster shots for seniors, declines them for healthcare workersGovernment advisors on Thursday recommended booster doses of Pfizer’s COVID-19 vaccine for millions of Americans.
Read more »
CDC advisory panel votes to recommend Pfizer boosters for people 65 and olderBREAKING: The CDC's independent advisory panel has unanimously voted to recommend booster doses of Pfizer's COVID vaccine for people aged 65 and older, along with long-term care facility residents, at least six months after their second dose.
Read more »
CDC Panel Outlines Who Should Get Pfizer-BioNTech COVID-19 Boosters, And Who Should WaitThe panel limited the additional dose to people who have already been vaccinated with the Pfizer-BioNTech COVID-19 vaccine
Read more »
CDC Panel Backs Pfizer Boosters for Select Groups, Notably SeniorsA panel of experts that advises the CDC on the use of vaccines in the U.S. has voted to approve third, booster doses for certain groups who initially got two doses of the Pfizer-BioNTech vaccine.
Read more »
COVID-19 live updates: CDC advisory panel expected to vote on Pfizer booster within hoursThe CDC’s independent advisory panel is set to vote this afternoon on which Americans are eligible now for a Pfizer booster.
Read more »
CDC panel recommends Pfizer boosters for high-risk individuals, people 65 and upA key panel at the Centers for Disease Control and Prevention on Thursday recommended the Pfizer-BioNTech coronavirus booster shots for people 65 years old and older, as well as those at high risk of severe COVID-19. Why it matters: The approval is the near-final step in making the booster shots available to tens of millions of Americans, and comes a day after the FDA approved Pfizer boosters for the two groups. CDC director Rochelle Walensky is expected to accept the recommendation.Stay on top
Read more »